Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other Non-Current Liabilities (2017 - 2024)

Utah Medical Products has reported Other Non-Current Liabilities over the past 11 years, most recently at $698000.0 for Q3 2024.

  • Quarterly results put Other Non-Current Liabilities at $698000.0 for Q3 2024, down 44.43% from a year ago — trailing twelve months through Sep 2024 was $698000.0 (down 44.43% YoY), and the annual figure for FY2023 was $698000.0, down 44.43%.
  • Other Non-Current Liabilities for Q3 2024 was $698000.0 at Utah Medical Products, roughly flat from $698000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for UTMD hit a ceiling of $2.2 million in Q3 2021 and a floor of $698000.0 in Q4 2023.
  • Median Other Non-Current Liabilities over the past 5 years was $1.7 million (2021), compared with a mean of $1.5 million.
  • Biggest five-year swings in Other Non-Current Liabilities: grew 3.0% in 2021 and later crashed 44.47% in 2024.
  • Utah Medical Products' Other Non-Current Liabilities stood at $2.0 million in 2020, then decreased by 16.04% to $1.7 million in 2021, then fell by 25.01% to $1.3 million in 2022, then tumbled by 44.43% to $698000.0 in 2023, then changed by 0.0% to $698000.0 in 2024.
  • The last three reported values for Other Non-Current Liabilities were $698000.0 (Q3 2024), $698000.0 (Q2 2024), and $698000.0 (Q1 2024) per Business Quant data.